Categories: News

NYSE Content Advisory: Pre-Market update + Amrize begins trading on the NYSE

NEW YORK, June 23, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on June 22nd

- Advertisement -
  • Equities are fractionally lower Monday morning after the U.S. took direct action to eliminate Iran’s nuclear program over the weekend. On Saturday, President Trump announced the U.S. struck three Iranian nuclear sites.
  • The strait of Hormuz, situated between Iran and Oman, is a major trade route for global oil shipments. How Iran responds and the availability of the passageway could impact markets around the world, including U.S. gas prices.
  • U.S. Secretary of State Marco Rubion Sunday called for the Chinese Government to prevent Iran from closing the strait. The world’s second largest economy is Iran’s most important oil customer.
  • Today, the NYSE welcomes a new company. Building solutions firm Amrize starts trading after completing its spin-off from Holcim. Amrize will trade under the ticker symbol AMRZ.

Opening Bell
Amrize (NYSE: AMRZ) celebrates its debut as an independent, publicly traded company

- Advertisement -

Closing Bell
ISDA marks its 40th anniversary

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2716651/NYSE_Market_Update_June_23.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–amrize-begins-trading-on-the-nyse-302488226.html

- Advertisement -

Recent Posts

Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head,…

2 hours ago

VigoSurge Claims Evaluated: Analyzing the Ingredients’ Benefits, Side Effects Risk and Customer Complaints

Aurora, CO, April 18, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes…

2 hours ago

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating…

2 hours ago

HTX DAO Completes Q1 2026 $HTX Burn: Two-Year Supply Shrinks Over 11% as Deflation Accelerates

PANAMA CITY, April 17, 2026 /PRNewswire/ -- Despite a turbulent first quarter characterized by market…

4 hours ago

DXC Expands Consulting & Engineering Services Leadership to Scale AI-led Growth

ASHBURN, Va., April 16, 2026 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology…

5 hours ago

Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I

The initiative is designed to support the tokenization and commercialization of 100 companies formed around…

9 hours ago